Sanofi (Sanofi) PEG Ratio

: 2.41 (As of Today)

View and export this data going back to 2009. Start your Free Trial

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Sanofi's PE Ratio without NRI is 14.44. Sanofi's 5-Year EBITDA growth rate is 6.00%. Therefore, Sanofi's PEG Ratio for today is 2.41.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

The historical rank and industry rank for Sanofi's PEG Ratio or its related term are showing as below:

SNYNF' s PEG Ratio Range Over the Past 10 Years
Min: 1.14 Med: 1.87 Max: 8.07
Current: 2.41

During the past 13 years, Sanofi's highest PEG Ratio was 8.07. The lowest was 1.14. And the median was 1.87.

SNYNF's PEG Ratio is ranked worse than
63.81% of 373 companies
in the Drug Manufacturers industry
Industry Median: 1.64 vs SNYNF: 2.41

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.

Sanofi PEG Ratio Historical Data

The historical data trend for Sanofi's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PEG Ratio

7.68

1.39

1.81

1.26

2.55

Sanofi Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
PEG Ratio																1.81	-	1.26	-	2.55

Competitive Comparison

For the Drug Manufacturers - General subindustry, Sanofi's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sanofi PEG Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Sanofi's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Sanofi's PEG Ratio falls into.

Sanofi PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Sanofi's PEG Ratio for today is calculated as

PEG Ratio	=	PE Ratio without NRI	/	5-Year EBITDA Growth Rate*
	=	14.443751947647	/	6.00
	=	2.41

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Sanofi (OTCPK:SNYNF) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.

Sanofi PEG Ratio Related Terms

Thank you for viewing the detailed overview of Sanofi's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Sanofi (Sanofi) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (OTCPK:SNYNF) » Definitions » PEG Ratio

Comparable Companies

Traded in Other Exchanges

SNY:USA SNY:Mexico SANF:Italy 0A2V:UK SANp:UK 0O59:UK SAN:France SNW:Germany SNW2:Germany SNW:Germany SNW:Germany SNW2:Germany SNW:Germany SANO:Austria

Address

46, avenue de la Grande Armée, Paris, FRA, 75017

Website

https://www.sanofi.com

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 15% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.